13F reference period
Q2 2026
Security Snapshot
bioAffinity Technologies, Inc. - Common Stock, $0.007 par value (BIAF) Institutional Ownership
CUSIP: 09076W307
13F Institutional Holders and Ownership History from Q3 2025 to Q3 2026
Institutions Reporting
20
Shares (Excl. Options)
805.91K
Full value: 805,912 · shares · 30 Jun 2026Price
$0.81
The headline uses the Q2 2026 reference period after its reporting deadline. Available reports may still be incomplete or amended. Newer periods in the history table contain incoming reports and may be incomplete.
Save this security page for your next review
Watchlists follow companies and investors, across their share classes. Bookmark this page to revisit this specific CUSIP and its quarterly holders. If you create an account from here, we will bring you back after verification.
- Security type / class
- Equity / Common Stock, $0.007 par value
- Symbol
- BIAF on Nasdaq
- All holders as of 30 Jun 2026
- Q2 2026
- Total 13F shares
- 805,912
- Total 13F value
- $782,494
- Portfolio coverage rank
- 0%
- Share change
- +563,710
- Value change
- +$379,538
- Number of holders
- 20
- Shares outstanding
- 2,027,012
- SEC-reported price per share
- $0.40
Latest holder snapshot
5 signals
Issuer context
Names, identifiers, and filing context for this profile.
2 identity fields
13F Shares, Excluding Options vs Price
13F Value, Excluding Options
Total Investors
Filing notes and source
Key facts
- BIAF - bioAffinity Technologies, Inc. - Common Stock, $0.007 par value is tracked under CUSIP 09076W307.
- 20 institutions reported positions in Q2 2026.
- 1 significant owner is listed from Schedule 13D/13G reporting.
Change
- Holder count moved from 14 to 20 between Q1 2026 and Q2 2026.
- SEC-reported value moved from to
$928.48K
Full value: $928,482 · USD · 31 Mar 2026.$782.49K
Full value: $782,494 · USD · 30 Jun 2026
Research use
- You can quickly see who holds this security, then open quarter and manager detail pages for full evidence.
- 13F and Schedule 13D/13G sections are kept together so you can cross-check institutional and beneficial ownership context.
Evidence
Source: SEC Form 13F
Open SEC evidence
Latest holder context comes from 20 institutions filings for Q2 2026.
Security key
09076W307
13F reference period
Q2 2026
13F holders
20
13D/G owners
1
CIK / CUSIP context first
Open Q2 2026 holders
BIAF full holder history
bioAffinity Technologies, Inc. SEC filings
bioAffinity Technologies, Inc. company facts
bioAffinity Technologies, Inc. insider transactions
Broader feeds
Recent Quarterly Holder Reports
Open recent reporting periods for CUSIP 09076W307:
13D/G owners
Significant owners
Large-stake holder rows connected to Schedule 13D/G evidence.
Rows
1
Security
BIAF
| Filer | Ownership | Change % | Holdings Value | Net Change | Nb Shares | Change % | Reporting Name | Report Period |
|---|---|---|---|---|---|---|---|---|
| BIGGER CAPITAL FUND L P | 5.8% | 117,364 | Bigger Michael | 29 Sep 2025 |
As of 30 Jun 2026,
20
institutional investors reported holding
shares of
bioAffinity Technologies, Inc. - Common Stock, $0.007 par value (BIAF).
This represents
40%
of the company’s total
outstanding shares.
805.91K
Full value: 805,912 · shares · 30 Jun 20262.03M
Full value: 2,027,012 · shares · Stored outstanding share count13F concentration
Top 24 institutional shareholders
Largest 13F positions for this security by reported shares and value.
Top holder share
40%
| Institution | Ownership % | Shares Held | Share Change % | Portfolio % | Holdings Value |
|---|---|---|---|---|---|
| SABBY MANAGEMENT, LLC | 18% | 365,647 | 2.5% | $296,905 | |
| BlackRock, Inc. | 4.9% | 98,777 | 0% | $80,207 | |
| VANGUARD CAPITAL MANAGEMENT LLC | 2.7% | 55,543 | 0% | 0% | $45,101 |
| GEODE CAPITAL MANAGEMENT, LLC | 2.5% | 50,967 | +5.5% | 0% | $41,384 |
| J. Safra Sarasin Holding AG | 2.1% | 42,600 | 0% | 0% | $164,010 |
| VANGUARD FIDUCIARY TRUST CO | 1.5% | 31,071 | 0% | 0% | $25,230 |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 1.3% | 26,870 | 0% | $21,818 | |
| JANE STREET GROUP, LLC | 1.3% | 26,784 | 0% | $21,748 | |
| STATE STREET CORP | 1.2% | 24,086 | +67% | 0% | $19,558 |
| HRT FINANCIAL LP | 1% | 20,834 | 0% | $16,000 | |
| NORTHERN TRUST CORP | 0.83% | 16,748 | +32% | 0% | $13,599 |
| Virtu Financial LLC | 0.55% | 11,113 | 0% | $9,000 | |
| Parrish Capital LLC | 0.51% | 10,418 | 0.01% | $8,459 | |
| Allworth Financial LP | 0.49% | 10,000 | 0% | $8,120 | |
| Tower Research Capital LLC (TRC) | 0.32% | 6,482 | +214% | 0% | $5,263 |
| UBS Group AG | 0.21% | 4,204 | -54% | 0% | $3,414 |
| EMC Capital Management | 0.1% | 2,001 | 0% | $1,000 | |
| ROYAL BANK OF CANADA | 0.05% | 931 | 0% | $1,000 | |
| IFP Advisors, Inc | 0.04% | 833 | 0% | 0% | $676 |
| MORGAN STANLEY | 0% | 3 | 0% | 0% | $2 |
| Caitong International Asset Management Co., Ltd | 0% | 0 | -100% | $0 | |
| CITIGROUP INC | 0% | 0 | -100% | $0 | |
| Schonfeld Strategic Advisors LLC | 0% | 0 | -100% | $0 | |
| Ameritas Advisory Services, LLC | 0% | 0 | -100% | $0 |
Quarter history
Institutional holders across reporting periods
Holder count, reported shares/value, and median price by quarter.
Periods
5
Headline period
Q2 2026
Rows shown
1-5 of 5